학술논문
P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE
Document Type
article
Author
Source
HemaSphere, Vol 7, p e8073255 (2023)
Subject
Language
English
ISSN
2572-9241